- Health Rising

Too Much Exertion Produces Autonomic Nervous System Hit in Long COVID, ME/CFS, and Fibromyalgia

Drug Under Development Spells Hope for Pain Relief in Fibromyalgia and Chronic Fatigue Syndrome

by Cort Johnson | Oct 13, 2013 | Allodynia, Drugs

A drug underdevelopment called NDPI could reduce the neuropathic pain in fibromyalgia and chronic fatigue syndrome

Subscribe To Health Rising’s Free Chronic Fatigue Syndrome, Fibromyalgia and Long COVID Information

Support Health Rising

BECOME A RECURRING DONOR

GIVE A ONE-TIME DONATION

HEALTH RISING IS NOT A 501 (c) 3 NON-PROFIT

Lives Interrupted

Lives Interrupted Latest Story

Knocked Out Of The Job Of a Lifetime

Bob Graybosch

Lahaina, United States

Former occupation: Resort General Manager

Total Economic Losses:

$1,261,443

Lives Interrupted Stats

Number of Stories: 44

Years of Work Lost: 337

Average Total Economic Losses:

$880,832

Total Economic Losses:

$28,186,628

StudyME

Enroll in the OMF’s StudyME project and help bring about a cure for ME/CFS, fibromyalgia, POTS and long COVID.

Find out more here

Enroll here

Stay Up to Date with ME/CFS, Long COVID and Fibromyalgia News

Get Health Rising's free blogs featuring the latest findings and treatment options for the ME/CFS, long COVID, fibromyalgia and complex chronic disease communities.

Too Much Exertion Produces Autonomic Nervous System Hit in Long COVID, ME/CFS, and Fibromyalgia

Drug Under Development Spells Hope for Pain Relief in Fibromyalgia and Chronic Fatigue Syndrome

Subscribe

Support Health Rising

Lives Interrupted

Lives Interrupted Latest Story

Lives Interrupted Stats

StudyME

Simmaron Research

ME/CFS & Fibromyalgia Treatment Room

May 12th - International ME/CFS & FM Awareness Day

Stay Up to Date with ME/CFS, Long COVID and Fibromyalgia News

Thank you for signing up!

Pin It on Pinterest